Trading Signals: LGND Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Ligand Pharmaceuticals Inc)
| LGND latest price $120.6200 (-2.62%) ($119.5000 - $123.8600) on Tue. May. 7, 2019. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.59% (three month average) | RSI | 46 | Latest Price | $120.6200(-2.62%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | LGND declines -0.8% a day on average for past five trading days. | Weekly Trend | LGND declines -0.3% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support LGND advance at 0% a week (0% probability) IBB(59%) IWO(57%) XBI(55%) IWC(54%) IWM(53%) | Factors Impacting LGND price | LGND will decline at least -1.295% in a week (0% probabilities). VXX(-15%) TLT(-15%) UUP(-10%) VIXM(-9%) IFRA(-8%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.295% (StdDev 2.59%) | Hourly BBV | 0 () | Intraday Trend | -1.7% | | | |
|
Resistance Level | $125.04 | 5 Day Moving Average | $123.79(-2.56%) | 10 Day Moving Average | $124.55(-3.16%) | 20 Day Moving Average | $125.04(-3.53%) | To recent high | -6.7% | To recent low | 13.9% | Market Cap | $1.938b | | | | Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in San Diego, CA. |